The impact of different antioxidant agents alone or in combination on reactive oxygen species, antioxidant enzymes and cytokines in a series of advanced cancer patients at different sites: correlation with disease progression.
about
Cachexia and pancreatic cancer: are there treatment options?The Janus-Faced Role of Antioxidants in Cancer Cachexia: New Insights on the Established ConceptsAlpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases.Treatment of cachexia in oncologyInvestigation of oxidative stress and dietary habits in Mongolian people, compared to Japanese people.Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexiaDrugs in development for treatment of patients with cancer-related anorexia and cachexia syndrome.THERAPEUTIC PERSPECTIVES ON THE COMBINATION OF ALPHA-LIPOIC ACID AND VITAMIN E.Current pharmacotherapy options for cancer anorexia and cachexia.Cisplatin : an old drug with a newfound efficacy -- from mechanisms of action to cytotoxicity.Induction of ER Stress-Mediated Apoptosis by α-Lipoic Acid in A549 Cell Lines.Biochemical and clinical relevance of alpha lipoic acid: antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential.Alpha-lipoic acid induces apoptosis in hepatoma cells via the PTEN/Akt pathway.Prognostic relevance of oxidative stress measurement in chronic lymphocytic leukaemia.Vitamin e and N-acetylcysteine as antioxidant adjuvant therapy in children with acute lymphoblastic leukemia.Comparative effects of α lipoic acid and melatonin on cisplatin-induced neurotoxicity.Oxidative stress, d-ROMs test, and ceruloplasmin.Polymeric micelles based on PEGylated chitosan-g-lipoic acid as carrier for efficient intracellular drug delivery.
P2860
Q27026558-36C0A4A6-A450-4F84-9413-59BA0D5EE1F1Q28078802-04289AD2-44F7-4D7B-882A-E8888E51A4E9Q34012029-136B991D-5BA3-4D45-BE22-CA2E40146796Q34158188-AC10394A-DAE7-4753-90CB-37E83448B79EQ34872183-5DC8A33E-2F92-4836-9566-DF11EE48F56FQ35583902-BBD72B6B-A12D-4DF8-B33A-EE2E3115999EQ37103603-C4C6EC8A-1A1F-4721-8F67-7E7C81B64AB7Q37782265-29126129-4DCC-4B92-87AC-E6CD9A55ADD0Q38052613-F16CF0D1-2D93-4554-A7D9-508D6FA992E9Q38123245-96B5E9DF-ABC6-415F-B949-8C76D6700186Q39390536-6046C4C6-23A5-4236-B765-34A513826A67Q39414338-CC79CCD3-D4CA-49AA-A311-26F7651A238DQ39988474-09C66E26-B367-41B9-B42A-CC4D85AFA489Q40147208-9355220C-FECE-429F-9D17-1691CB42659AQ42641741-0A0717A0-9C15-420D-9348-8E082E78D4DCQ42860457-A7081458-AA75-412C-8D01-E8CD2625CA99Q46615380-74DA849A-6DD8-4C2E-BA75-0FE6D286B4D5Q51012255-50ACF403-9E91-4876-B9F5-DF70A67655DA
P2860
The impact of different antioxidant agents alone or in combination on reactive oxygen species, antioxidant enzymes and cytokines in a series of advanced cancer patients at different sites: correlation with disease progression.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
The impact of different antiox ...... tion with disease progression.
@en
The impact of different antiox ...... tion with disease progression.
@nl
type
label
The impact of different antiox ...... tion with disease progression.
@en
The impact of different antiox ...... tion with disease progression.
@nl
prefLabel
The impact of different antiox ...... tion with disease progression.
@en
The impact of different antiox ...... tion with disease progression.
@nl
P2093
P356
P1476
The impact of different antiox ...... tion with disease progression.
@en
P2093
Antonio Macciò
Clelia Madeddu
Elena Massa
Giovanni Mantovani
Giulia Gramignano
Loredana Mura
Luca Ferreli
Maria Rita Lusso
Miria Mocci
Paolo Camboni
P304
P356
10.1080/10715760303849
P577
2003-02-01T00:00:00Z